Figure 6

Napiergram for compound A and B. The unbound exposure ranges versus different preclinical and clinical endpoints or biomarkers using the same data as in Figure 4. The Knowledge Plot concept has been applied to Compound B, where the exposure range above the Meaningful Effect level is shown by change in color (from blue to green).